Hyderabad, India -- (SBWIRE) -- 01/22/2018 -- According to a new market research report " Alzheimer's Disease Therapeutics and Diagnostics Market by Therapeutics (Marketed Drugs-(NMDA Receptor Antagonists, Cholinesterase Inhibitors), Pipeline Drugs), and by Diagnostics (Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others) - Global Forecast to 2021", published by Market Data Forecast™, the market is expected to reach USD 14.43 billion by 2021 from USD 9.97 billion in 2016, at a CAGR of 6.5%. Factors driving the growth of this market include growing old age population, rising R&D investment, high frequency of Alzheimer's and neurodegenerative diseases, and improved life expectancy of the general population.

Browse Market Data Tables and Figures spread through 178 Pages and in-depth TOC on "Alzheimer's Disease Therapeutics and Diagnostics "
https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-therapeutics-and-diagnostics-market-2247/
Early buyers will receive 10% customization on this report

Discuss the opportunities of the market
Marketed Drugs are estimated to account for the largest market share in 2016

On the basis of Therapeutics is segmented into Marketed Drugs and Pipeline Drugs. Marketed Drugs are further segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the global market on the basis of Therapeutics due to a large user base.

Customized Report: https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-
therapeutics-and-diagnostics-market-2247/customize-report

On the basis of Diagnostics, the global Alzheimer's disease Therapeutics and Diagnostics market is segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. .

Inquire: https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-therapeutics-and-diagnostics-market-2247/request-sample

North America is estimated to command the largest share of the market
Based on region, the Alzheimer's disease Therapeutics and Diagnostics Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the Alzheimer's Disease Therapeutics and Diagnostics Market in 2016. This is attributed to factors such as due to the growing prevalence of Alzheimer's disease and extensive technological developments in the region as compared to other regions.

Key players in the Alzheimer's Disease Therapeutics and Diagnostics Market include Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals etc.

The scope of the report provides:

The evaluation of the current market for your product or services and the future implications of the market

Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future

Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment

Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share

The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter's Five Forces

The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments

Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.

Browse Related Reports

Cardiac Assist Devices Market by Type {Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pumps (IABP) & Total Artificial Heart (TAH)}, and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2017 – 2022)
https://www.marketdataforecast.com/market-reports/global-cardiac-assist-devices-market-25/

Patient Monitoring Market by Application (Neurology, Hemodynamic, cardiac, Fetal and neonatal, Respiratory, Multi parameter, remote patient monitors, Temperature monitors and Weight monitoring systems), and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2017 – 2022)
https://www.marketdataforecast.com/market-reports/global-patient-monitoring-market-135/

Hybrid MRI Systems Market by Field Strength (Low -to mid -Field, High Field, Very High Field, Ultra High Field) by Type (X-Ray/MRI, PET/MRI, Radiography/MRI, MPI/MRI) & Application (Brain, Pelvic, Cardiac, Abdominal, Musculoskeletal) and by Region – Global Industry Analysis, Share, Size, Growth, Trends, and Forecasts (2016-2021)
https://www.marketdataforecast.com/market-reports/global-hybrid-mri-systems-market-2489/

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626